Skip to content

Kinesio Tape Application in the Treatment of Plantar Fasciitis

Can Kinesio Tape Negatively Affect the Treatment by Creating a Hard Floor in Plantar Fasciitis Treatment: A Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06516393
Enrollment
42
Registered
2024-07-24
Start date
2023-09-13
Completion date
2024-04-30
Last updated
2024-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fascitis

Keywords

Plantar Fasciitis, Radial Extracorporeal Shock Wave Therapy, Kinesio Taping, Pain

Brief summary

This study is a prospective randomized clinical trial. Radial extracorporeal shock wave therapy (r-ESWT) is accepted as one of the most effective treatment modalities for plantar fasciitis (PF). Kinesio taping (KT) applied to the plantar fascia can provide patients with PF some benefits, but there no enough evidence about this topic. This study analysed the acute effect of adding KT to r-ESWT, on pain, foot function and flexibility when treating PF.

Detailed description

The study was performed on 42 patients with unilateral PF, that were randomly assigned into wo groups receiving four sessions of either r-ESWT or r-ESWT+KT treatment once per week. All patients performed home exercises. Patients' pain levels were evaluated via the Visual Analogue Scale (VAS), and foot function via the Foot Function Index (FFI). Flexibility was assessed through gastro-soleus and plantar fascia flexibility tests. The evaluations were done before and one week after the final treatment.

Interventions

DEVICEThe radial shock wave device

The r-ESWT+Kinesio Tape Application

Sponsors

Bihter Aslanyurek
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

the patients were divided into subgroups by the sports physician according to age, height, body weight and body mass index. Patients with similar characteristics were randomized to one of two groups.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of unilateral plantar fasciitis, * The presence of a heel spur on a lateral radiograph

Exclusion criteria

* Lower extremity surgeries or traumas, * Systemic inflammatory disease, * Steroid injections administered within the past six months, * Pacemaker usage, * Coagulation disorders, * Use of anticoagulants.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in pain on the Visual Analog Scale (VAS) at week 5Baseline and week 5VAS is a tool where patients indicate the level of pain they feel using a 10 cm ruler. VAS pain score no pain (score=0) and worst pain (score=10).
Change from baseline Foot function via the Foot Function Index (FFI) at week 5Baseline and week 5FFI is a safe and valid foot-specific assessment measure used to evaluate pain, disability, and activity limitation, filled out by the patient self-reported
Change from baseline flexibility was evaluated through gastro-soleus and plantar fascia flexibility tests at week 5Baseline and week 5The patient was seated on a flat surface with the knees extended and the soles of the feet touching the wall. The tests were repeated three times and the average of the three measurements was taken.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026